BIOMAT Database Logo BIOMAT Database Logo

Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation--clinical and immunological considerations. 1995

H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany.

Veno-occlusive disease (VOD) is a frequent complication early after bone marrow transplantation. In cases of severe liver failure treatment by allogeneic liver transplantation is possible. We report the clinical and immunological course of a patient after bone marrow transplantation for AML and subsequent allogeneic liver transplantation for severe hepatic VOD. After liver transplantation the patient recovered well clinically. Early after liver transplantation he had large numbers of liver donor T and NK lymphocytes in his circulation. He had no liver graft rejection, but he developed mild acute GVHD which was caused by liver graft-derived T lymphocytes. Two years after transplantation he had persistent microchimerism with donor liver cells detectable in his bone marrow. Now 36 months after transplantation, the patient has no evidence of recurrent leukemia, stable liver function, and no signs of graft-versus-host disease or bone marrow dysfunction.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D008297 Male Males
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006504 Hepatic Veno-Occlusive Disease Liver disease that is caused by injuries to the ENDOTHELIAL CELLS of the vessels and subendothelial EDEMA, but not by THROMBOSIS. Extracellular matrix, rich in FIBRONECTINS, is usually deposited around the HEPATIC VEINS leading to venous outflow occlusion and sinusoidal obstruction. Sinusoidal Obstruction Syndrome,Veno-Occlusive Disease, Hepatic,Hepatic Veno Occlusive Disease,Disease, Hepatic Veno-Occlusive,Hepatic Veno-Occlusive Diseases,Syndrome, Sinusoidal Obstruction,Veno Occlusive Disease, Hepatic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Hepatic veno-occlusive disease after bone marrow transplantation.
January 1984, Hepatology (Baltimore, Md.),
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
September 1992, Bone marrow transplantation,
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation.
June 1992, Lancet (London, England),
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Alteplase for hepatic veno-occlusive disease after bone marrow transplantation.
August 1992, Lancet (London, England),
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Hepatic stellate cells (Ito cells) in veno-occlusive disease of the liver after allogeneic bone marrow transplantation.
January 1999, Histopathology,
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia.
September 2000, Bone marrow transplantation,
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Hepatic veno-occlusive disease following bone marrow transplantation.
January 1989, Oncology nursing forum,
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Hepatic veno-occlusive disease in a patient with lupus anticoagulant after allogeneic bone marrow transplantation.
August 1991, Bone marrow transplantation,
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
November 1991, Bone marrow transplantation,
H J Schlitt, and H J Tischler, and B Ringe, and G Raddatz, and H Maschek, and H Dietrich, and E Kuse, and R Pichlmayr, and H Link
Alteplase for hepatic veno-occlusive disease complicating bone-marrow transplantation.
April 1992, Lancet (London, England),
Copied contents to your clipboard!